2 found dead in Blairstown incident - more >>


Senator Casey urges FDA to review heroin overdose antidote

WASHINGTON, D.C. - Senator Casey questioned the FDA's recent approval of a new painkiller, Zohydro, and asked that the status of naloxone, a drug that reverses heroin overdoses, be reviewed Thursday during a hearing of the Health Education Labor and Pensions Committee.

"Families and communities across Pennsylvania have struggled with the disease of addiction. It's vital that we take steps to help these families, our medical professionals and law enforcement in this effort," Senator Casey said in a news release. "I have serious concern about the FDA's approval of Zohydro and the impact it could have for those struggling with addiction."

Casey also wants the FDA to make lifesaving doses of naloxone more accessible.

According to Casey's new release, the commissioner of the FDA recognized the importance of drugs like naloxone and "pledged to make progress on abuse deterrent technology that could reduce the addictive potential of drugs like Zohydro."

Due to our site relaunch on October 25, previous comments on existing stories are no longer available.  This change is due to the limitations of Facebook's software 

The views expressed are not those of this company or its affiliated companies. Please note by clicking on "Post" you acknowledge that you have read the TERMS OF USE  and the comment you are posting is in compliance with such terms. Your comments may be used on air. Be polite. Inappropriate posts or posts containing offsite links may be removed by the moderator.

Allentown, PA 18102





  • %

This Week's Circulars

Top Stories

Latest from the newsroom

More from the Newsroom